Precordior provides world-leading solutions for the detection of complex and life-threatening cardiac conditions using its proprietary patent-protected technology, enabling fast and reliable cardiac analysis using just a regular smartphone. As no separate measurement equipment or add-on device is required, only Precordior’s mobile app and a cloud service, the company enjoys virtually unlimited growth potential in any global region. Precordior Ltd is an ISO 13485 certified company, and its current solution for the detection of atrial fibrillation via smartphone is a certified CE Class IIa medical device. The company currently has 21 granted patents and global trademark protection. Precordior is committed to helping healthcare providers, employers, and governments to minimize unnecessary healthcare expenditure and enable a longer and healthier life for all.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Precordior Ltd founded?
Precordior Ltd was founded in 2016.
What industry is Precordior Ltd in?
Precordior Ltd operates in Medical Devices. Find similar Medical Devices investors on gritt.io.
Where is Precordior Ltd based?
Precordior Ltd is headquartered in Turku, Finland.
Find investors for your startup like Precordior Ltd
Gritt sends AI-personalised outreach to each investor — from your Gmail